Detalhe da pesquisa
1.
Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial.
Lancet
; 394(10212): 1929-1939, 2019 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31590988
2.
SUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
J Transl Med
; 17(1): 429, 2019 12 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31878938
3.
Pseudomonas aeruginosa Bacteremic Patients Exhibit Nonprotective Antibody Titers Against Therapeutic Antibody Targets PcrV and Psl Exopolysaccharide.
J Infect Dis
; 213(4): 640-8, 2016 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26333940
4.
Blood Aspergillus RNA is a promising alternative biomarker for invasive aspergillosis.
Med Mycol
; 54(8): 801-7, 2016 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27335056
5.
Efavirenz modulation of sleep spindles and sleep spectral profile.
J Sleep Res
; 24(1): 66-73, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25113527
6.
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial.
J Clin Oncol
; 42(1): 47-58, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870536
7.
Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging.
J Magn Reson Imaging
; 37(6): 1359-70, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23172799
8.
Willingness to undergo a repeat liver biopsy among HIV/hepatitis C virus-coinfected and hepatitis C virus-monoinfected patients.
J Clin Gastroenterol
; 47(5): 457-60, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23328300
9.
NEPTUNE China cohort: First-line durvalumab plus tremelimumab in Chinese patients with metastatic non-small-cell lung cancer.
Lung Cancer
; 178: 87-95, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36806898
10.
Biomarker expression and survival in patients with non-small cell lung cancer receiving adjuvant chemotherapy in Denmark.
PLoS One
; 18(4): e0284037, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37040387
11.
Metaprotein expression modeling for label-free quantitative proteomics.
BMC Bioinformatics
; 13: 74, 2012 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-22559859
12.
Distribution of hepatitis C virus genotypes in a diverse US integrated health care population.
J Med Virol
; 84(11): 1744-50, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22997077
13.
Interferon gamma expression and mortality in unselected cohorts of urothelial bladder cancer patients.
PLoS One
; 17(8): e0271339, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36040901
14.
Association between immune-mediated adverse events and efficacy in metastatic non-small-cell lung cancer patients treated with durvalumab and tremelimumab.
Front Immunol
; 13: 1026964, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36405729
15.
Test-retest repeatability of MR elastography for noninvasive liver fibrosis assessment in hepatitis C.
J Magn Reson Imaging
; 34(4): 947-55, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21751289
16.
Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens.
J Infect Dis
; 201(5): 712-9, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20105080
17.
PD-L1 expression, EGFR and KRAS mutations and survival among stage III unresected non-small cell lung cancer patients: a Danish cohort study.
Sci Rep
; 11(1): 16892, 2021 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34413420
18.
Programmed cell death ligand-1 expression and survival in a cohort of patients with non-small cell lung cancer receiving first-line through third-line therapy in Denmark.
Cancer Epidemiol
; 73: 101976, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34217914
19.
STK11 (LKB1) mutations in metastatic NSCLC: Prognostic value in the real world.
PLoS One
; 15(9): e0238358, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32881920
20.
Design and Rationale for a Phase III, Randomized, Placebo-controlled Trial of Durvalumab With or Without Tremelimumab After Concurrent Chemoradiotherapy for Patients With Limited-stage Small-cell Lung Cancer: The ADRIATIC Study.
Clin Lung Cancer
; 21(2): e84-e88, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31948903